FTC Tries Again On K-Dur; Joins Pharmacies, DoJ In Appeal Of Reverse Settlement Case
This article was originally published in The Pink Sheet Daily
Executive Summary
Strength of patent is a focus of FTC's amicus brief; the Commission acknowledges that it has inappropriately ignored the issue in the past.